Jerome Barakos

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Juha O. Rinne, David J. Brooks, Martin N. Rossor et al. · The Lancet Neurology · 2010 · 694 citations

Neurodegenerative Diseases, Ascending-dose Study, Alzheimer's Disease +10

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

Stephen Salloway, Spyros Chalkias, Frederik Barkhof et al. · JAMA Neurology · 2021 · 544 citations · Full text

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

Reisa A. Sperling, Stephen Salloway, David J. Brooks et al. · The Lancet Neurology · 2012 · 497 citations · Full text

Alzheimer's Disease, Dementia, Retrospective Analysis +6

Novel symptomatology and changing epidemiology of domoic acid toxicosis in California sea lions ( <i>Zalophus californianus</i> ): an increasing risk to marine mammal health

Tracey Goldstein, Jonna A. K. Mazet, Tanja S. Zabka et al. · Proceedings of the Royal Society B Biological Sciences · 2007 · 204 citations · Full text

Ecotoxicity, Domoic Acid, Engineering +22

Orbit, skull base, and pharynx: contrast-enhanced fat suppression MR imaging.

Jerome Barakos, W P Dillon, W Chew · Radiology · 1991 · 133 citations

Engineering, Pet-mri, Surgery +20